Ensysce Biosciences (ENSCW) Receivables (2021 - 2025)
Historic Receivables for Ensysce Biosciences (ENSCW) over the last 5 years, with Q3 2025 value amounting to $8.9 million.
- Ensysce Biosciences' Receivables changed N/A to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is 8403.24% down from last year.
- According to the latest figures from Q3 2025, Ensysce Biosciences' Receivables is $8.9 million.
- Ensysce Biosciences' Receivables' 5-year high stood at $10.9 million during Q2 2022, with a 5-year trough of $1.7 million in Q4 2024.
- Moreover, its 5-year median value for Receivables was $8.9 million (2025), whereas its average is $6.6 million.
- In the last 5 years, Ensysce Biosciences' Receivables plummeted by 8403.24% in 2024 and then soared by 39924.04% in 2025.
- Quarter analysis of 5 years shows Ensysce Biosciences' Receivables stood at $2.9 million in 2021, then soared by 279.58% to $10.9 million in 2022, then fell by 1.07% to $10.8 million in 2023, then plummeted by 84.03% to $1.7 million in 2024, then soared by 416.46% to $8.9 million in 2025.
- Its last three reported values are $8.9 million in Q3 2025, $10.6 million for Q2 2025, and $9.2 million during Q1 2025.